DEA: Special Registrations for Telemedicine and Limited State Telemedicine Registrations

Federal Register

Jan 17, 2025

Notice of proposed rulemaking from the Drug Enforcement Administration (DEA) proposing regulatory changes aimed at expanding patient access to controlled substance medications via telemedicine while mitigating the risks of diversion associated with such expansion. Proposed changes would establish a Special Registration framework and authorize three types of Special Registration that would allow more comprehensive prescribing, including prescribing of Schedule II and narcotic and non-narcotic controlled substances in limited circumstances, by properly registered physicians and mid-level practitioners and dispensing by online telemedicine platforms that constitute covered online telemedicine platforms. Comments are due by March 18, 2025.

Access · Behavioral health · Health workforce · Legislation and regulations · Pharmacy and prescription drugs · Telehealth